Anson Funds Management’s Sonoma Pharmaceuticals, Inc. Warrants SNOAW Stock Holding History

Anson Funds Management’s Portfolio SNOAW Stock Details SNOAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-171,851	Closed	-$1.23M	–	62
2017 Q1	$1.23M	Sell	171,851 -30,163	-15%	-$15.2K	0.51%	25
2016 Q4	$1.02M	Buy	+202,014	New	+$74K	0.32%	33

Other funds holding SNOAW

MIG

Mariner Investment Group Harrison, New York $346M AUM 25.25% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Anson Funds Management's SNOAW Position: Q2 2017 in Review

Anson Funds Management sold out of Sonoma Pharmaceuticals, Inc. Warrants (SNOAW) in Q2 2017, closing a stake of 171,851 shares — an estimated $1.23M sold.

Anson Funds Management first reported a position in SNOAW in Q4 2016 and held it in 2 quarters. The position peaked at $1.23M in Q1 2017. 3 funds tracked by Wall St. Rank hold SNOAW as of Q2 2017.

Anson Funds Management reported no remaining Sonoma Pharmaceuticals, Inc. Warrants position as of Q2 2017 after selling out during the quarter.
Anson Funds Management sold 171,851 Sonoma Pharmaceuticals, Inc. Warrants shares in Q2 2017, an estimated $1.23M.
Anson Funds Management first reported a position in Sonoma Pharmaceuticals, Inc. Warrants in Q4 2016 and held it in 2 quarters.
Anson Funds Management's Sonoma Pharmaceuticals, Inc. Warrants position peaked at $1.23M in Q1 2017.
3 funds tracked by Wall St. Rank held Sonoma Pharmaceuticals, Inc. Warrants as of Q2 2017.

Based on Anson Funds Management's 13F filing for Q2 2017, filed 14 Aug 2017.